Showing results (1121-1130 of 1,984) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|August 2, 2016
Surgical treatment for epilepsy: the potential gap between evidence and practiceNathalie Jetté, Josemir W Sander, Mark R KeezerThe Lancet. Neurology|August 7, 2016
Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trialSonoko Misawa, Yasunori Sato, Kanako Katayama, et al.The Lancet. Neurology|June 13, 2015
Lower urinary tract dysfunction in the neurological patient: clinical assessment and managementJalesh N Panicker, Clare J Fowler, Thomas M KesslerThe Lancet. Neurology|June 13, 2015
Neurological and neuropsychiatric aspects of tuberous sclerosis complexPaolo Curatolo, Romina Moavero, Petrus J de VriesThe Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.The Lancet. Neurology|July 4, 2015
The interface between delirium and dementia in elderly adultsTamara G Fong, Daniel Davis, Matthew E Growdon, et al.The Lancet. Neurology|August 21, 2021
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a studyJ William L Brown, Nick G Cunniffe, Ferran Prados, et al.The Lancet. Neurology|August 21, 2021
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyElisabeth H Thijssen, Renaud La Joie, Amelia Strom, et al.The Lancet. Neurology|August 21, 2021
Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Yael Hacohen, Alvaro Cobo-Calvo, et al.The Lancet. Neurology|August 2, 2021
Post-viral effects of COVID-19 in the olfactory system and their implicationsMichael S Xydakis, Mark W Albers, Eric H Holbrook, et al.Pageof 199